医薬品不足情報を
お知らせください

詳しくはこちら

供給情報モニター施設
（薬局・医療機関）を
募集しています（無償）

詳しくはこちら

海外医薬品の不足情報・医薬政策情報等を
デイリーで発信中

国内不足状況

一覧を見る

諸外国不足状況

  • 2025.10.21 [ 英国 ]
    NICE医薬品情報サービス（2025年10月13日〜2025年10月17日）

    Medicine supply notification: Dalivit® oral drops

    Dalivit® oral drops are out of stock until further notice. Abidec® multivitamin drops remain available and can support increased demand, but as it contains arachis oil (peanut oil), it should not be taken by patients with peanut or soya allergy.

    Further Information

     

    Medicine supply notification: Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen

    Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pens have been discontinued with supplies now exhausted. Alternative GLP-1 RAs and dual GIP/GLP-1 RA remain available and can support increased demand.

     

  • 2025.10.20 [ ドイツ ]
    BfArMボトルネック・レポート（2025年10月13日～10月19日）
    Active ingredients
    Message type
    		Date of last messageType of reasonAM designation
    Lidocaine hydrochloride monohydrateChange notification17.10.2025OtherXylocaine Gel 2%
    EstriolInitial report17.10.2025OtherOvestin 1 mg cream
    Mivacurium chlorideInitial report17.10.2025OtherMivacron 10 mg
    LidocaineInitial report17.10.2025OtherXYLOCAIN PUMP SPRAY dental
    Salbutamol sulfateChange notification17.10.2025OtherSultanol forte ready-to-use inhalation solution
    Levothyroxine sodiumInitial report17.10.2025Production problemL-thyroxine Henning 50
    Levothyroxine sodiumInitial report17.10.2025Production problemL-thyroxine Henning 125
    Levothyroxine sodiumInitial report17.10.2025Production problemL-Thyroxine Henning 75
    Gentamicin sulfateInitial report17.10.2025Production problemGentamicin-POS
    Phenylephrine hydrochlorideChange notification17.10.2025Production problemNeosynephrine-POS 5%
    FampridineChange notification17.10.2025OtherFAMPRIDIN BASICS 10 mg prolonged-release tablets
    Atorvastatin calcium trihydrate (Ph.Eur.)Initial report17.10.2025OtherATORVASTATIN BASICS 80 mg film-coated tablets
    Olanzapine embonate monohydrateInitial report17.10.2025OtherZYPADHERA 405 mg powder and solvent for the preparation of a prolonged-release injection suspension – OP(931mg+3ml)
    Candesartan cilexetilInitial report17.10.2025OtherATACAND 16 mg
    Olanzapine embonate monohydrateChange notification17.10.2025Production problemZYPADHERA 210 mg powder and solvent for the preparation of a prolonged-release suspension for injection – OP(483mg+3ml)
    Methyldopa (Ph.Eur.)Initial report17.10.2025Production problemPresinol 250
    Insulin detemirInitial report17.10.2025OtherLevemir 100 IU solution for injection in pre-filled pen – OP(10x3ml)(FlexPen)
    Insulin detemirInitial report17.10.2025OtherLevemir 100 IU injection solution in cartridge – OP(10x3ml)
    Betamethasone dipropionate (Ph.Eur.); gentamicin sulfateInitial report16.10.2025OtherDiprogenta
    PosaconazoleInitial report16.10.2025OtherPosaconazole HEXAL 40 mg/ml oral suspension
    OxytocinInitial report16.10.2025Production problemOxytocin 3 IU Hexal
    Human insulin (with manufacturing details)Initial report16.10.2025OtherBerlinsulin H Basal 3 ml pen
    Insulin aspartChange notification16.10.2025OtherNovoMix 30 FlexPen 100 IU/ml injection suspension in pre-filled syringe – OP(10x3ml)
    Human insulin (with manufacturing details)Initial report15.10.2025OtherBerlinsulin H Normal 3 ml pen
    MethylprednisoloneInitial report15.10.2025OtherMethylprednisolone 4mg JENAPHARM
    Azithromycin dihydrateChange notification15.10.2025OtherAzithromycin AL 250 mg film-coated tablets
    Vancomycin hydrochlorideChange notification15.10.2025Production problemVancomycin Lyomark 500 mg
    Vancomycin hydrochlorideChange notification15.10.2025Production problemVancomycin Lyomark 1000 mg powder for concentrate for solution for infusion or oral solution
    PosaconazoleInitial report15.10.2025OtherPosaconazole AL 40 mg/ml oral suspension
    Methylphenidate hydrochlorideInitial report15.10.2025OtherMetiphenal 10 mg modified-release hard capsules
    Folic acid hydrate (with information on water content (1:x))Initial report15.10.2025OtherFolic acid AL 5 mg tablets
    AcitretinInitial report15.10.2025OtherAcicutan 25 mg hard capsules
    Fusidic acid (Ph.Eur.)Initial report15.10.2025OtherFusicutan ointment
    OxazepamInitial report15.10.2025OtherDurazepam 50 mg forte
    Oxycodone hydrochloride (Ph.Eur.)Initial report14.10.2025Production problemOxygesic Dispersa acute 5 mg
    Oxycodone hydrochloride (Ph.Eur.)Initial report14.10.2025Production problemOxygesic Dispersa acute 10 mg
    Oxycodone hydrochlorideChange notification14.10.2025OtherOXYGESIC 10 mg
    Arsenic(III) oxideInitial report14.10.2025OtherTRISENOX 2 mg/ml concentrate for solution for infusion
    Granisetron hydrochlorideInitial report14.10.2025OtherKevatril 3 mg/3 ml solution for injection
    CarboplatinInitial report14.10.2025OtherCarboplatin Kabi 10 mg/ml concentrate for solution for infusion
    Dexketoprofen trometamolInitial report14.10.2025Production problemSympal inject 50 mg injection/infusion solution
    Tolterodine tartrateInitial report14.10.2025OtherDetrusitol 2 mg film-coated tablets
    Doxepin hydrochloride (Ph.Eur.)Initial report14.10.2025OtherDoxepin-ratiopharm 50 mg film-coated tablets
    Doxepin hydrochloride (Ph.Eur.)Initial report14.10.2025OtherDoxepin-ratiopharm 25 mg film-coated tablets
    ThiamazoleInitial report13.10.2025OtherThiamazole 5 mg Henning
    Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y)Change notification13.10.2025OtherFerrlecit 62.5 mg
    Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y)Change notification13.10.2025OtherFerrlecit 40 mg
    Cisatracurium besylateChange notification13.10.2025OtherNimbex 10 mg
    ZolbetuximabChange notification13.10.2025OtherVyloy
    Paliperidone palmitateInitial report13.10.2025OtherXEPLION 50 mg prolonged-release suspension for injection – OP1ml
  • 2025.10.20 [ フランス ]
    （ANSMフランス供給不足情報（2025年10月13日～10月19日）
    Active ingredientsStatutUpdateSpecialty
    digoxineSupply tension10/17/2025Digoxine Nativelle 5 µg/0.1 ml, solution buvable en gouttes
    pyrantel (embonate of)Supply tension10/17/2025Combantrin 125 mg, tablet
    rifamycin sodiumSupply tension10/17/2025Rifamycin Chibret 1000 000 IU per cent, eye drops solution
    risperidoneSupply tension10/17/2025Risperidone 0.5 mg, 1 mg, 2 mg and 3 mg orodispersible tablet
    risperidoneOut of stock10/17/2025Risperidone 4 mg Orodispersible tablet
    olipudase alfaSupply tension15/10/2025Xenpozyme 20 mg, powder for solution to be diluted for infusion
    pertuzumab/trastuzumabOut of stock15/10/2025Phesgo 1200 mg/600 mg, solution injectable
    risperidoneOut of stock15/10/2025RisperdalConsta L.P. 37.5 mg/2 ml, powder and solvent for prolongedrelease suspension for injection in prefilled syringe
    risperidoneSupply tension15/10/2025RisperdalConsta L.P. 50 mg/2 ml and 25 mg/2 ml, powder and solvent for prolongedrelease suspension for injection in prefilled syringe
    risperidoneOut of stock15/10/2025Risperidone L.P. 25 mg/2 ml, 37.5 mg/2 ml and 50 mg/2 ml, powder and solvent for prolongedrelease suspension for injection in prefilled syringe
    lenalidomideOut of stock15/10/2025Lenalidomide Mylan, capsule
    dipyridamoleSupply tension15/10/2025Persantine 10 mg/2 mL, solution injectable, ampoule
    chlorpromazine (hydrochloride)Supply tension13/10/2025Largactil 25 mg, filmcoated tablet
    VaricellaZoster Virus (VZV) glycoprotein E antigen (recombinant, adjuvanted) (mammalian/hamster/CHO cells)Supply tension13/10/2025Shingrix, powder and suspension for injectable suspension. Varicella zoster vaccine (recombinant, adjuvanted)
    esketamine (hydrochloride)Return to availability13/10/2025Eskesia 5 mg/mL, solution for injection/infusion  10 glass ampoule(s) of 5 ml
  • 2025.10.20 [ オーストラリア ]
    TGAオーストラリア供給不足情報（2025年10月13日～10月19日）
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    desvenlafaxineTablet, modified release100 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability20/10/2025
    desvenlafaxineTablet, modified release50 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability20/10/2025
    ezetimibe~simvastatinTablet10 mg~40 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply20/10/2025
    risperidoneOral Liquid, solution1 mg/mLCurrentLimited AvailabilityManufacturing20/10/2025
    rivaroxabanTablet, film coated10 mgAnticipatedAvailableManufacturing20/10/2025
    rifampicinCapsule, hard150 mgCurrentLimited AvailabilityManufacturing20/10/2025
    phenytoin sodiumInjection, solution100 mgCurrentUnavailableManufacturing17/10/2025
    ciprofloxacin hydrochlorideTablet, film coated555 mgAnticipatedAvailableManufacturing17/10/2025
    sildenafil citrateTablet, uncoated35.1 mgCurrentLimited AvailabilityManufacturing17/10/2025
    glipizideTablet, uncoated5 mgAnticipatedAvailableManufacturing17/10/2025
    mesalazineTablet, modified release1 gCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues17/10/2025
    atorvastatin calcium trihydrateTablet, film coated21.69 mgCurrentUnavailableManufacturing17/10/2025
    atorvastatin calcium trihydrateTablet, film coated43.38 mgCurrentLimited AvailabilityManufacturing17/10/2025
    montelukast sodiumTablet, chewable5.2 mgAnticipatedAvailableManufacturing17/10/2025
    carbidopa monohydrate~levodopa~entacaponeTablet, film coated54 mg~200 mg~200 mgCurrentUnavailableManufacturing17/10/2025
    entacapone~carbidopa monohydrate~levodopaTablet, film coated200 mg~20.25 mg~75 mgCurrentUnavailableManufacturing17/10/2025
    entacapone~levodopa~carbidopa monohydrateTablet, film coated200 mg~50 mg~13.5 mgCurrentLimited AvailabilityManufacturing17/10/2025
    levodopa~entacapone~carbidopa monohydrateTablet, film coated100 mg~200 mg~27 mgCurrentUnavailableManufacturing17/10/2025
    entacapone~levodopa~carbidopa monohydrateTablet, film coated200 mg~125 mg~33.75 mgCurrentUnavailableManufacturing17/10/2025
    carbidopa monohydrate~levodopa~entacaponeTablet, film coated40.5 mg~150 mg~200 mgCurrentUnavailableManufacturing17/10/2025
    pregabalinCapsule, hard150 mgCurrentLimited AvailabilityUnexpected increase in consumer demand17/10/2025
    risperidoneTablet, film coated2 mgAnticipatedAvailableManufacturing17/10/2025
    gabapentinTablet, film coated600 mgAnticipatedAvailableManufacturing17/10/2025
    metaraminol tartrateInjection, solution19 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply17/10/2025
    amlodipine besilate~olmesartan medoxomil~hydrochlorothiazideTablet, film coated13.9 mg~40 mg~12.5 mgAnticipatedAvailableManufacturing17/10/2025
    naltrexone hydrochlorideTablet, film coated50 mgAnticipatedAvailableManufacturing17/10/2025
    tranexamic acidTablet, film coated500 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply17/10/2025
    prazosin hydrochlorideTablet, uncoated1.095 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply16/10/2025
    tobramycinInjection, solution80 mgAnticipatedAvailableManufacturing16/10/2025
    tetracosactideInjection, modified release1 mg/mLCurrentUnavailableManufacturing16/10/2025
    dienogest~ethinylestradiolTablet, sugar coated2 mg~.03 mgAnticipatedAvailableManufacturing16/10/2025
    codeine phosphate hemihydrateOral Liquid, solution5 mg/mLCurrentUnavailableManufacturing16/10/2025
    ciprofloxacin hydrochlorideTablet, film coated277.5 mgCurrentUnavailableManufacturing16/10/2025
    ciprofloxacin hydrochlorideTablet, film coated832.5 mgAnticipatedAvailableManufacturing16/10/2025
    midazolamInjection, solution5 mg/mLAnticipatedAvailableManufacturing16/10/2025
    olsalazine sodiumCapsule250 mgCurrentUnavailableManufacturing16/10/2025
    finasterideTablet, film coated1 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply16/10/2025
    lumefantrine~artemetherTablet, dispersible120 mg~20 mgDiscontinuedUnavailableCommercial Changes / Commercial viability16/10/2025
    bisoprolol fumarateTablet5 mgAnticipatedAvailableManufacturing16/10/2025
    levetiracetamTablet, film coated500 mgCurrentLimited AvailabilityManufacturing16/10/2025
    pramipexole dihydrochloride monohydrateTablet.125 mgCurrentUnavailableManufacturing16/10/2025
    pramipexole dihydrochloride monohydrateTablet.25 mgCurrentUnavailableManufacturing16/10/2025
    pramipexole dihydrochloride monohydrateTablet1 mgAnticipatedAvailableManufacturing16/10/2025
    montelukast sodiumTablet, chewable4.16 mgCurrentUnavailableManufacturing16/10/2025
    montelukast sodiumTablet, chewable4.16 mgCurrentUnavailableManufacturing16/10/2025
    sildenafil citrateTablet, film coated28.1 mgCurrentUnavailableManufacturing16/10/2025
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~41.583 mgResolvedAvailableManufacturing16/10/2025
    oxytocinInjection, solution5 IU/mLResolvedAvailableUnexpected increase in consumer demand16/10/2025
    oxytocinInjection, solution10 IU/mLResolvedAvailableManufacturing16/10/2025
    atorvastatin calcium trihydrate~ezetimibeTablet, multilayer10.9 mg~10 mgResolvedAvailableManufacturing16/10/2025
    ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in consumer demand16/10/2025
    nicorandilTablet, uncoated10 mgCurrentLimited AvailabilityManufacturing16/10/2025
    tadalafilTablet, film coated5 mgCurrentLimited AvailabilityManufacturing16/10/2025
    latanoprostEye Drops, solution.05 mg/mLAnticipatedAvailableManufacturing16/10/2025
    escitalopram oxalateTablet, film coated25.47 mgCurrentLimited AvailabilityManufacturing16/10/2025
    eplerenoneTablet, film coated25 mgResolvedAvailableManufacturing16/10/2025
    lacosamideTablet, film coated50 mgAnticipatedAvailableManufacturing16/10/2025
    ambrisentanTablet, film coated5 mgAnticipatedAvailableManufacturing16/10/2025
    nitrofurantoinCapsule, hard100 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply16/10/2025
    methylphenidate hydrochlorideTablet, modified release54 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply16/10/2025
    methylphenidate hydrochlorideTablet, modified release27 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply16/10/2025
    olsalazine sodiumTablet, uncoated500 mgCurrentUnavailableManufacturing16/10/2025
    estradiol hemihydrateDrug delivery system, transdermal3.09 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply16/10/2025
    hydrochlorothiazide~enalapril maleateTablet, uncoated6 mg~20 mgAnticipatedAvailableManufacturing16/10/2025
    valaciclovir hydrochlorideTablet, film coated1112 mgCurrentLimited AvailabilityManufacturing16/10/2025
    estradiol hemihydrateDrug delivery system, transdermal2.32 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply16/10/2025
    galantamine~galantamine hydrobromideCapsule, modified release16 mg~20.51 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply16/10/2025
    diclofenac sodiumTablet, enteric coated50 mgDiscontinuedUnavailableCommercial Changes / Commercial viability15/10/2025
    propranolol hydrochlorideTablet, film coated10 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability15/10/2025
    propranolol hydrochlorideTablet, film coated40 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability15/10/2025
    alfentanil hydrochlorideInjection, solution1.0876 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues15/10/2025
    pregabalinCapsule, hard150 mgResolvedAvailableManufacturing15/10/2025
    pregabalinCapsule, hard75 mgResolvedAvailableManufacturing15/10/2025
    dabigatran etexilate mesilateCapsule, hard126.83 mgResolvedAvailableManufacturing15/10/2025
    lurasidone hydrochlorideTablet, film coated80 mgCurrentUnavailableManufacturing15/10/2025
    rivaroxabanTablet, film coated15 mgAnticipatedAvailableManufacturing15/10/2025
    levothyroxine sodiumTablet50 microgramCurrentUnavailableUnexpected increase in consumer demand15/10/2025
    metronidazoleTablet, film coated400 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply15/10/2025
    rifampicinCapsule, hard300 mgCurrentUnavailableManufacturing15/10/2025
    clopidogrel hydrogen sulfateTablet, film coated97.875 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply15/10/2025
    diclofenac sodiumTablet, enteric coated25 mgDiscontinuedUnavailableCommercial Changes / Commercial viability14/10/2025
    valaciclovir hydrochlorideTablet, film coated556.275 mgResolvedAvailableManufacturing14/10/2025
    methylphenidate hydrochlorideCapsule, modified release10 mgCurrentLimited AvailabilityManufacturing14/10/2025
    ephedrine sulfateInjection, solution30 mg/mLAnticipatedAvailableManufacturing14/10/2025
    montelukast sodiumTablet, chewable5.2 mgResolvedAvailableManufacturing14/10/2025
    primaquine phosphateTablet, uncoated13.2 mgAnticipatedAvailableManufacturing14/10/2025
    methylphenidate hydrochlorideCapsule, modified release60 mgCurrentUnavailableManufacturing14/10/2025
    olmesartan medoxomil~hydrochlorothiazideTablet20 mg~12.5 mgAnticipatedAvailableManufacturing14/10/2025
    atenololTablet, film coated50 mgCurrentUnavailableManufacturing14/10/2025
    nebivolol hydrochlorideTablet1.363 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability14/10/2025
    metoprolol succinateTablet, modified release23.75 mgResolvedAvailableManufacturing14/10/2025
    levothyroxine sodiumTablet100 microgramCurrentUnavailableUnexpected increase in consumer demand14/10/2025
    methylphenidate hydrochlorideCapsule, modified release20 mgCurrentLimited AvailabilityManufacturing14/10/2025
    methylphenidate hydrochlorideCapsule, modified release30 mgCurrentLimited AvailabilityManufacturing14/10/2025
    methylphenidate hydrochlorideCapsule, modified release40 mgCurrentUnavailableManufacturing14/10/2025
    phenytoin sodiumInjection, solution250 mgAnticipatedAvailableManufacturing13/10/2025
    lidocaine hydrochlorideInjection, solution20 mg/mLResolvedAvailableManufacturing13/10/2025
    adrenaline (epinephrine) acid tartrate~lidocaine hydrochlorideInjection, solution9.1 microgram/mL~20 mg/mLResolvedAvailableManufacturing13/10/2025
    venlafaxine hydrochlorideCapsule, modified release84.86 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply13/10/2025
    ethinylestradiol~drospirenoneTablet30 microgram~3 mgCurrentLimited AvailabilityManufacturing13/10/2025
    galantamine hydrobromideCapsule, modified release10.252 mgCurrentUnavailableManufacturing13/10/2025
    milrinoneInjection, concentrated10 mgCurrentLimited AvailabilityManufacturing13/10/2025
    irbesartanTablet, film coated150 mgCurrentUnavailableManufacturing13/10/2025
    montelukast sodiumTablet, chewable5.2 mgCurrentUnavailableManufacturing13/10/2025
    potassium chlorideTablet, modified release600 mgResolvedAvailableManufacturing13/10/2025
    lacosamideTablet, film coated100 mgResolvedAvailableManufacturing13/10/2025
    phenytoin sodiumInjection, solution100 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability13/10/2025
    bromazepamTablet, uncoated6 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues13/10/2025
    cisatracurium besilateInjection, solution2.68 mg/mLResolvedAvailableManufacturing13/10/2025
    pramipexole dihydrochloride monohydrateTablet, uncoated.25 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply13/10/2025
    spironolactoneTablet, film coated25 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply13/10/2025
  • 2025.10.20 [ 米国 ]
    ASHP供給不足情報（2025年10月13日～10月19日）
    Generic NameShortage StatusRevision Date
    Erythromycin Lactobionate InjectionCurrent Shortages17-Oct-25
    Methylphenidate Immediate-Release TabletsCurrent Shortages17-Oct-25
    Acetaminophen InjectionCurrent Shortages16-Oct-25
    Amoxicillin and Clavulanate Oral PresentationsCurrent Shortages16-Oct-25
    Ascorbic Acid InjectionCurrent Shortages16-Oct-25
    Fludarabine InjectionCurrent Shortages16-Oct-25
    Furosemide InjectionCurrent Shortages16-Oct-25
    Heparin InjectionCurrent Shortages16-Oct-25
    Leucovorin Calcium InjectionCurrent Shortages16-Oct-25
    Levofloxacin Injection in 5% DextroseCurrent Shortages16-Oct-25
    Lidocaine InjectionCurrent Shortages16-Oct-25
    Meperidine Hydrochloride InjectionCurrent Shortages16-Oct-25
    5% Dextrose Injection (PVC-free and DEHP-free)Resolved Shortages15-Oct-25
    Amphetamine Mixed Salts, Immediate-Release TabletsCurrent Shortages15-Oct-25
    Cromolyn Oral SolutionCurrent Shortages15-Oct-25
    Dextroamphetamine Extended-Release CapsulesCurrent Shortages15-Oct-25
    Methylphenidate Extended Release Oral PresentationsCurrent Shortages15-Oct-25
    Mometasone Furoate Aerosol for Oral InhalationCurrent Shortages14-Oct-25
    Morphine InjectionCurrent Shortages14-Oct-25
    Octreotide Intramuscular Injection KitsCurrent Shortages14-Oct-25
    Penicillin V Potassium Oral PresentationsCurrent Shortages14-Oct-25
    Prednisone Oral TabletsCurrent Shortages14-Oct-25
    Scopolamine Transdermal SystemCurrent Shortages14-Oct-25
    Acetazolamide InjectionCurrent Shortages13-Oct-25
    Adenosine InjectionCurrent Shortages13-Oct-25
    Amino Acid ProductsCurrent Shortages13-Oct-25
    Aminocaproic Acid InjectionCurrent Shortages13-Oct-25
    Chlorothiazide Sodium InjectionCurrent Shortages13-Oct-25
    Clindamycin Phosphate InjectionCurrent Shortages13-Oct-25
    Dexamethasone Oral Solution/ElixirCurrent Shortages13-Oct-25
    Dextran Low Molecular Weight (Dextran 40), 10% InjectionCurrent Shortages13-Oct-25
    Diazepam InjectionCurrent Shortages13-Oct-25
    Methotrexate InjectionCurrent Shortages13-Oct-25
    Midazolam InjectionCurrent Shortages13-Oct-25
    Nitrofurantoin Oral SuspensionCurrent Shortages13-Oct-25
一覧を見る

供給関連情報

一覧を見る

医薬政策情報

一覧を見る

NEWS

一覧を見る

製薬会社、研究者、医療機関
の皆さまへ

賛助会員になると、さらに詳しい医薬情報の提供、共同研究、コンサルティングなど、当法人の専門的なサポートが受けられます。

賛助会員の詳細・お申込みはこちら
このページの先頭へ戻る